158 related articles for article (PubMed ID: 29909754)
21. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A
Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218
[TBL] [Abstract][Full Text] [Related]
22. The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma.
Hong H; Fang X; Huang H; Wang Z; Lin T; Yao H
Br J Haematol; 2020 Jun; 189(5):908-912. PubMed ID: 32103494
[TBL] [Abstract][Full Text] [Related]
23. Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma.
Huang C; Zhang H; Gao Y; Diao L; Liu L
Technol Cancer Res Treat; 2020; 19():1533033820964231. PubMed ID: 33073702
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
[TBL] [Abstract][Full Text] [Related]
25. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China.
Wei C; Li W; Qin L; Liu S; Xue C; Ren K; Zhang Z; Liu C; Bao F; Zhang H; Zhou H; Li Z; Wu H; Zou L; Liu L; Jing H; Zhang W
Cancer Med; 2023 Feb; 12(4):3987-3998. PubMed ID: 36106610
[TBL] [Abstract][Full Text] [Related]
27. A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
Kurita D; Miyoshi H; Yoshida N; Sasaki Y; Kato S; Niino D; Sugita Y; Hatta Y; Takei M; Makishima M; Ohshima K
Am J Surg Pathol; 2016 Sep; 40(9):1249-60. PubMed ID: 27428734
[TBL] [Abstract][Full Text] [Related]
28. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
[TBL] [Abstract][Full Text] [Related]
29. Angioimmunoblastic T-cell lymphoma management.
Mosalpuria K; Bociek RG; Vose JM
Semin Hematol; 2014 Jan; 51(1):52-8. PubMed ID: 24468316
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics and prognosis in 84 patients with angioimmunoblastic T-cell lymphoma: a single-center analysis].
Li TT; Luo LT; Chen Y; Yang T; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):915-920. PubMed ID: 33333694
[No Abstract] [Full Text] [Related]
31. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
[TBL] [Abstract][Full Text] [Related]
32. Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.
Koyama S; Fujisawa S; Watanabe R; Itabashi M; Ishibashi D; Ishii Y; Hattori Y; Nakajima Y; Motohashi K; Takasaki H; Kawasaki R; Hashimoto C; Yamazaki E; Koharazawa H; Takemura S; Tomita N; Sakai R; Motomura S; Nakajima H
Int J Lab Hematol; 2017 Feb; 39(1):112-117. PubMed ID: 27885817
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.
Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M
Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095
[TBL] [Abstract][Full Text] [Related]
34. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
35. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic model for angioimmunoblastic T-cell lymphoma: A retrospective study of 55 cases.
Sun J; He S; Cen H; Zhou D; Li Z; Wang MY; Ke Q; Guo BP; Liao CC; Rong C; Zhong DN; Tan XH
J Int Med Res; 2021 May; 49(5):3000605211013274. PubMed ID: 34034561
[TBL] [Abstract][Full Text] [Related]
37. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
Federico M; Bellei M; Marcheselli L; Schwartz M; Manni M; Tarantino V; Pileri S; Ko YH; Cabrera ME; Horwitz S; Kim WS; Shustov A; Foss FM; Nagler A; Carson K; Pinter-Brown LC; Montoto S; Spina M; Feldman TA; Lechowicz MJ; Smith SM; Lansigan F; Gabus R; Vose JM; Advani RH;
Br J Haematol; 2018 Jun; 181(6):760-769. PubMed ID: 29672827
[TBL] [Abstract][Full Text] [Related]
38. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
[TBL] [Abstract][Full Text] [Related]
39. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.
Mitrovic Z; Perry AM; Suzumiya J; Armitage JO; Au WY; Coiffier B; Holte H; Jaffe ES; Monserrat E; Rajan SK; Savage KJ; Tobinai K; Vose JM; Weisenburger DD
Am J Hematol; 2012 Aug; 87(8):790-4. PubMed ID: 22488678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
